Cambridge Heart (NSDQ:CAMH) remained in the red in its 3rd quarter after the company restructured its operations in July, but narrowed its losses by 16.6%.
2012
Losses gape, sales narrow for BSD Medical
BSD Medical Corp. (NSDQ:BSDM) saw its losses increase by more than 50% during fiscal 2012, as sales decreased by nearly 32%.
The Salt Lake City-based medical device company reported losses of $8.0 million, or 27¢ per share, on sales of $2.1 million during the 12 months ended August 31.
The news sent BSDM shares down 5.9% to $1.93 apiece as of about noon today.
Hologic guides low for 2013, expecting $25M impact of the device tax
HeartWare revenue grows, losses widen in Q3
HeartWare International (NSDQ:HTWR) saw strong growth in its sales in the 3rd quarter, but increased its losses by 79% compared with the same period last year.
Covidien jumps on fiscal 2012 results, confirms 2013 outlook
Covidien (NYSE:COV) shares got a jolt on Wall Street this morning after the medical device company reported strong fiscal 2012 results and confirmed its outlook for next year.
Investors had added 5.3% to COV’s price as of about 11:45 this morning, sending shares to $56.18 despite a nearly 3% sales slide that just beat expectations on The Street.
Given imaging surges in Q3 net income; shares down
Given Imaging saw moderate growth in revenue during its 3rd quarter, and posted a 60% increase in net income.
The Israel-based medical device maker posted $6 million in profit, or 19¢ per share on sales of $45.4 million for the 3 months ended Sept. 30. That compared with a net income of $3.8 million, or 12¢ per share on sales of $44.7 million during the same period last year.
Siemens Healthcare’s 2012 profits soar 36%
Siemens (NYSE:SI) saw its fiscal 2012 profits plunge by more than 27%, despite a strong contribution from its healthcare segment.
The German industrial conglomerate reported profits of about $5.85 billion (€4.59 billion), or $6.43 per share (€5.04), on sales of $99.81 billion (€78.30 billion) during the 12 months ended Sept. 30. That’s a top-line gain of 6.9%, but a bottom-line plunge of 27.4%.
Insulet gains after hours on Q3 results
Insulet (NSDQ:PODD) shares gained after the market’s close today after the medical device company reported strong sales growth and lower losses for the 3rd quarter.
Bedford, Mass.-based Insulet reported losses of $12.4 million, or 26¢ per share, on sales of $54.8 million during the 3 months ended Sept. 30, reducing losses by some 8.4%.
Mako slides again on missed procedure volumes, lowered outlook
Mako Surgical (NSDQ:MAKO) shares are once again under pressure on Wall Street, with investors spooked by lower-than-expected procedure volumes during the 3rd quarter, despite a more than 45% sales increase and significantly reduced losses.
Becton Dickinson expects medtech tax to cut 3% from next year’s bottom line
Becton Dickinson & Co. (NYSE:BDX) is expecting the medical device tax to cut about 3% off of its 2013 earnings growth, chairman, president & CEO Vincent Forlenza said during an earnings call this week.
Syneron Medical narrows Q3 losses by 94%, shares down 5.4%
Syneron Medical (NSDQ:ELOS) remained in the red during its 3rd quarter, but managed to narrow its losses by 94.3% compared with the same period last year.